NFKB1 and colorectal carcinoma: Certain studies showed [16] that XCHT might inhibit CRC progression in a chronic stress mouse CRC model by inhibiting the NLRP3 inflammasome activity and pro-inflammatory factor secretion, just as well as by down-regulating NF-κB.